Delivery Order SPE2DB25D3020-SPE2DB25FWKLA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,848.19 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units under a firm fixed-price contract with a ceiling value of $1,225.04. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, non-set-aside procurement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This firm fixed-price delivery order, issued on June 16, 2025, carries a ceiling value of $2,450.08 and is scheduled for completion by June 17, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order and is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Nucynta 50 mg tablets (100-count units) with a ceiling value of $1,837.56. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of September 25, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 50 mg tablets (100-count package) with a ceiling value of $1,225.04. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKLADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $1,845.89 and ultimate completion date of September 5, 2025. The contract carries no set-aside designation and represents a competitive award. Performance of this delivery order is based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This parent IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs globally. The Nucynta delivery represents a pain management pharmaceutical fulfillment consistent with the company's extensive portfolio of therapeutic product categories supplied to federal customers including the Defense Health Agency and U.S. Coast Guard through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/4/25 |